Acutus Medical, Inc. (AFIB)

USD 0.03

(6.67%)

Net Debt Summary of Acutus Medical, Inc.

  • Acutus Medical, Inc.'s latest annual net debt in 2023 was 12.27 Million USD , down -7.48% from previous year.
  • Acutus Medical, Inc.'s latest quarterly net debt in 2024 Q1 was 20 Million USD , up 3.63% from previous quarter.
  • Acutus Medical, Inc. reported annual net debt of 13.27 Million USD in 2022, down -37.78% from previous year.
  • Acutus Medical, Inc. reported annual net debt of 21.33 Million USD in 2021, up 34.63% from previous year.
  • Acutus Medical, Inc. reported quarterly net debt of 22.51 Million USD for 2024 Q2, up 12.52% from previous quarter.
  • Acutus Medical, Inc. reported quarterly net debt of 14.83 Million USD for 2023 Q3, down -5.69% from previous quarter.

Annual Net Debt Chart of Acutus Medical, Inc. (2023 - 2018)

Historical Annual Net Debt of Acutus Medical, Inc. (2023 - 2018)

Year Net Debt Net Debt Growth
2023 12.27 Million USD -7.48%
2022 13.27 Million USD -37.78%
2021 21.33 Million USD 34.63%
2020 15.84 Million USD -49.99%
2019 31.67 Million USD 95.07%
2018 16.24 Million USD 0.0%

Peer Net Debt Comparison of Acutus Medical, Inc.

Name Net Debt Net Debt Difference
Biotricity, Inc. 23.09 Million USD 46.827%
Cell MedX Corp. 244.05 Thousand USD -4931.325%
Dynatronics Corporation 6.2 Million USD -97.92%
Nemaura Medical Inc. 9.92 Million USD -23.718%
PetVivo Holdings, Inc. 1.27 Million USD -861.071%
RetinalGenix Technologies Inc. 506.53 Thousand USD -2324.122%
Sonendo, Inc. 26.34 Million USD 53.386%
Telesis Bio, Inc. 32.63 Million USD 62.375%
Talis Biomedical Corporation -57.06 Million USD 121.518%
Viveve Medical, Inc. -13.81 Million USD 188.895%